Current state of immunotherapy for glioblastoma | Nature Reviews Clinical Oncology
Cells | Free Full-Text | Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies
Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells | Nature Communications
Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells | Nature Communications
Frontiers | Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
Frontiers | Immunotherapy for Glioblastoma: Current Progress and Challenges
Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
Brain immunology and immunotherapy in brain tumours | Nature Reviews Cancer
Brain Sciences | Free Full-Text | Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I) | HTML
Cells | Free Full-Text | Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies
Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma | Nature Communications
Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells - ScienceDirect
Cytovac | Brain Cancer
Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
Advances in local therapy for glioblastoma — taking the fight to the tumour | Nature Reviews Neurology
Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells - ScienceDirect
Frontiers | Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
Natural bioactive molecules: An alternative approach to the treatment and control of glioblastoma multiforme - ScienceDirect
Correlation Between Blood Count and the in vitro Effect of ALECSAT on... | Download Table
Cells | Free Full-Text | Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies
Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells - ScienceDirect
Cancers | Free Full-Text | Current Immunotherapeutic Strategies for the Treatment of Glioblastoma
Overview of current immunotherapeutic strategies for glioma | Immunotherapy
Overview of current immunotherapeutic strategies for glioma | Immunotherapy
Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them | British Journal of Cancer
